Most Australian women using IVF pay for add-on treatments with ‘weak’ evidence behind them, research finds
By Joseph Dunstan,
ABC News
| 05. 03. 2021
Most women undergoing IVF treatment in Australia are paying for one or more add-on treatments, despite limited proof of their effectiveness, new research has found.
Key points:
- Researchers found 82 per cent of women paid for an add-on during IVF treatment
- Acupuncture, pre-implantation genetic testing and Chinese herbal medicine were the three most common treatments
- Lead author Sarah Lensen said the evidence base for many of the add-on treatments was weak
Researchers from Australia, the United Kingdom and the Victorian IVF regulator VARTA found 82 per cent of 1,590 women surveyed had used an additional treatment while undergoing IVF.
Lead author and University of Melbourne researcher Sarah Lensen said the most common add-on treatments identified in the survey were acupuncture, pre-implantation genetic testing of embryos for abnormal chromosomes and Chinese herbal medicine.
But Dr Lensen said the evidence base for the treatments was “rather weak.”
“None of the add-ons that they use in Australia are supported by high quality, robust evidence that they help people to have a baby from IVF and that they're safe to use,” she said.
“There is...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...
